Understanding Head Defects: Normal vs Optimal Ranges

Also known as: congenital head abnormalities, cranial defects, birth defects of the head

Prenatal & Developmental

?What is Head Defects?

Head defects are congenital abnormalities affecting the structure or development of the skull, brain, or associated tissues. These may include anencephaly, spina bifida, hydrocephalus, or other malformations of cranial structures. Detection typically occurs through prenatal screening, imaging, or clinical examination.

!Why It Matters

Head defects can have significant implications for neurological function, developmental outcomes, and quality of life. Early identification through screening may guide prenatal care, birth planning, and post-natal intervention strategies. Understanding risk factors and prevention opportunities is important for family planning and maternal health.

Reference Ranges

Range TypeMinMaxUnitNote
Lab NormalStandard lab reference range
OptimalEvidence-based optimal range for health
Longevity TargetPer longevity medicine research (Attia et al.)

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

  • Abnormal head shape or size on ultrasound
  • Elevated maternal serum alpha-fetoprotein (AFP)
  • Developmental delays or neurological signs after birth
  • Visible cranial asymmetry or bulging fontanelle
  • Seizures or movement abnormalities in severe cases

How to Improve Your Levels

  • 1Ensure adequate maternal folic acid supplementation (400–800 mcg daily) before and during pregnancy
  • 2Optimize maternal nutritional status, including B vitamins and micronutrients
  • 3Avoid teratogenic substances such as certain medications, alcohol, and smoking during pregnancy
  • 4Maintain good glycemic control if diabetic, as maternal hyperglycemia increases risk
  • 5Attend regular prenatal screening and ultrasound appointments for early detection
  • 6Work with maternal-fetal medicine specialists if risk factors are identified

When to Test

Prenatal screening is typically performed during the second trimester (15–20 weeks gestation) via maternal serum markers and ultrasound. First-trimester nuchal translucency screening may also be offered. Testing is recommended for all pregnancies and is especially important if there is a family history of congenital defects or maternal risk factors.

Related Biomarkers

Track your Head Defects with ByoMap

Upload your blood report and get personalized Head Defects ranges based on your age, sex, and ancestry — free.

Try Free — Upload Your Report